![Ovid Therapeutics (OVID) Upgraded to Buy: Here’s Why](https://staticx-tuner.zacks.com/images/default_article_images/default36.jpg)
Ovid Therapeutics (OVID) Upgraded to Buy: Here’s Why
ZacksOvid Therapeutics (OVID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ovid Therapeutics (OVID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).